HeadInvest LLC’s Aurora Cannabis ACB Stock Holding History

HeadInvest LLC’s Portfolio ACB Stock Details ACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1	Closed	-$5	–	234
2023 Q3	$5	Buy	+1	New	+$6	﹤0.01%	749

Other funds holding ACB

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

YRHAM

Yong Rong (HK) Asset Management Sheung Wan, Hong Kong $227M AUM 300.38% 1-Year Est. Return

AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

HeadInvest LLC's ACB Position: Q4 2023 in Review

HeadInvest LLC sold out of Aurora Cannabis (ACB) in Q4 2023, closing a stake of 1 share — an estimated $5 sold.

HeadInvest LLC first reported a position in ACB in Q3 2023 and held it in 1 quarter. The position peaked at $5 in Q3 2023. 201 funds tracked by Wall St. Rank hold ACB as of Q4 2023.

HeadInvest LLC reported no remaining Aurora Cannabis position as of Q4 2023 after selling out during the quarter.
HeadInvest LLC sold 1 Aurora Cannabis share in Q4 2023, an estimated $5.
HeadInvest LLC first reported a position in Aurora Cannabis in Q3 2023 and held it in 1 quarter.
HeadInvest LLC's Aurora Cannabis position peaked at $5 in Q3 2023.
201 funds tracked by Wall St. Rank held Aurora Cannabis as of Q4 2023.

Based on HeadInvest LLC's 13F filing for Q4 2023, filed 12 Feb 2024.